How Family Offices Should Approach Investment in the Life Sciences and Healthcare Industry

Posted June 14, 2018 by OCP | Post a Comment

The fundraising landscape for healthcare and life science companies has changed dramatically over the past several years. Entrepreneurs and business owners in these industries need to look toward emerging categories of investors to provide the funding that was historically serviced by venture capital firms (VC’s). Corporate venture funds, angels and angel networks, government agencies, and foundations are all actively investing in these sectors and represent newer, non-traditional avenues for raising capital. However, the latest growing trend is the participation of family offices.

(more…)

Healthcare, Life Sciences, Blog Article, Buy-Side M&A

SoCal Capital Summit on M&A Healthcare Trends & Opportunities

Posted November 04, 2017 by OCP | Post a Comment

 

Objective Capital’s David H. Crean to be Guest Panelist at ACG Orange County's CEO Signature Event on November 15, 2017

San Diego, November 6, 2017 — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, will be a guest panelist speaker at ACG Orange County’s CEO Signature Event entitled SoCal Capital Summit on November 15, 2017.   Dr. Crean and the fellow panelists will address M&A Healthcare Trends and Opportunities.  He will be joined by Greg Cunniff, CFO, NVISION Eye Centers, and Steven Shill, Partner and National Healthcare Practice Leader at BDO.

(more…)

Healthcare, Life Sciences, Press News, Buy-Side M&A, Sell-Side M&A

NRC Health and Practicing Excellence Form Strategic Alliance

Posted September 19, 2017 by OCP | Post a Comment

Objective Capital Partners Acted as Financial Advisor to Practicing Excellence

San Diego, CA- September 25, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce the successful closing of one of its advisory engagements with Practicing Excellence upon its strategic alliance with and investment from NRC Health. Practicing Excellence, the developer of an online skill-building platform, connects clinicians to practical, evidence-based, colleague-tested tools designed to enhance the delivery of patient care and improve the overall physician experience.

(more…)

Healthcare, Life Sciences, Press News, Buy-Side M&A, Sell-Side M&A

Global Health Solutions Retains Objective Capital Partners As Exclusive Advisor for Acquiring Strategic Partnerships

Posted May 12, 2017 by OCP | Post a Comment

San Diego, CA, May 15, 2017 Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, has announced that it has been retained as exclusive advisor to Global Health Solutions, LLC, to assist the company in exploring strategic partnerships and licensing agreements for its diverse product portfolio and pipeline for wound care, infection, and skin care. The priority focus will be on seeking best in class commercialization partners for the Company’s 510K FDA-cleared Hexagen™ Wound Dressing, which addresses the pressing need for effective solutions in the chronic and advanced wound market(s).  Additional assets to be partnered include the FiltreX™ Adhesive Dressing and pipeline assets in dermatology, infection control, biologics, and aesthetics.

(more…)

Healthcare, Life Sciences, Press News, Buy-Side M&A, Strategic Advisory

Objective Capital Partners Channing Hamlet to Address Mergers & Acquisitions in Today’s Economic Environment

Posted January 12, 2017 by OCP | Post a Comment

San Diego, CA- January 16, 2017 - Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that Channing Hamlet, one of its Managing Directors, will be a guest panelist speaker at CONNECT’s Frameworks Workshop on February 2, 2017 from 8:00-11:30 AM. Mr. Hamlet will be joined by fellow panelists Clark Libenson, Corporate Partner at Allen Matkins, and Allen Walburn, Tax Partner at Allen Matkins. The panel will address the important topic of Mergers & Acquisition in Today’s Economic Environment. The event is sponsored by Allen Matkins and will be held at the offices of CONNECT, 4790 Eastgate Mall, San Diego, CA 92121.

(more…)

Press News, Buy-Side M&A, Sell-Side M&A

Objective Capital Partner’s Channing Hamlet to Address Value of Investment Bankers in Company Sale Transaction

Posted September 26, 2016 by OCP | Post a Comment

San Diego, CA – September 27, 2016- Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that Channing Hamlet, one of its Managing Directors, will be a guest panelist speaker at the Association for Corporate Growth (ACG) San Diego meeting to be held on Tuesday, October 18, 2016.  Mr. Hamlet will be joined by fellow panelists Steve Moon, Managing Director of Duff & Phelps Securities, John Henberger, Jr., President of Henberger Group and Jeremiah Mann, Managing Director of Intrepid Investment Bankers.  The panel will be moderated by Bill Lynch, VP of ProFinance, and will address the important topic of How Investment Bankers Increase Company Sale Value. A separate breakout session will be conducted after the program specifically for C-Level executives and business owners to allow them to ask questions of the panelists and speakers. The event is sponsored by BDO, Procopio and Vantage Point and will be held at Lomas Santa Fe Country Club in Solana Beach, CA from 7-9 AM. Breakfast is provided with registration for the event.

(more…)

Business Valuation, Press News, Buy-Side M&A, Sell-Side M&A

It’s All About the Exit -A Fireside Chat With Bob Nascenzi and Objective Capital’s Trever Acers

Posted September 13, 2016 by OCP | Post a Comment

San Diego, CA – September 14, 2016- Objective Capital Partners is pleased to announce that Trever Acers, one of its Managing Directors, will be a guest speaker in a fireside chat alongside Bob Nascenzi to address important topics in the exit of a business on October 5, 2016.  The event is sponsored by MIT Enterprise Forum San Diego and will be held a National University, Sanford Center in La Jolla, CA from 5-7 PM.  

(more…)

Press News, Buy-Side M&A, Sell-Side M&A

Featured in Mergers & Acquisitions Magazine

Posted October 20, 2015 by OCP | Post a Comment

Objective Capital Partners grows by adding a Life Science Investment Banking practice lead by Dr. David Crean PhD.  Featured in Mergers & Acquisitions Magazine online edition.  

(more…)

Press News, Buy-Side M&A, Sell-Side M&A

This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.

Our Services

Learn about our services and how we can help you sell your business successfully.

LEARN MORE

Contact Us

San Diego Office:
3636 Nobel Dr., Suite 160
San Diego, CA 92122

Los Angeles Office:
10100 Santa Monica Blvd., Suite 300
Los Angeles, CA 90067

Trever Acers
Managing Director
858.663.8662 telephone
trever.acers@objectivecp.com

Channing Hamlet
Managing Director
858.342.4939 telephone
channing.hamlet@objectivecp.com

David H. Crean, Ph.D.
Managing Director
858.461.9490 telephone
david.crean@objectivecp.com

Jack J. Florio
Managing Director
858.864.4339 telephone
jack.florio@objectivecp.com